The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease
Open accessAbstract
Interactions of the presynaptic proteins, neuronal pentraxin 2 (NPTX2) and neurexin 2α (NRXN22α), with their respective postsynaptic functional partners, GluA4‐containing glutamate (AMPA4) receptor and neuroligin 1 (NLGN1), enhance excitatory synaptic activity in some areas of the hippocampus and cerebral cortex. As early damage of such excitatory circuits in the brain tissues of participants with Alzheimer's disease (AD) correlates with cognitive losses, plasma neuron‐derived exosome (NDE) levels of these 2 pairs of specialized synaptic proteins were quantified to assess their biomarker characteristics. The NDE contents of all 4 proteins were decreased significantly in AD dementia ( n = 46), and diminished levels of AMPA4 and NLGN1 correlated with the extent of cognitive loss. In a preclinical period, 6–11 yr before the onset of dementia, the NDE levels of all but NPTX2 were significantly lower than those of matched controls, and levels of all proteins declined significantly with the development of dementia. Reductions in NDE levels of these specialized excitatory synaptic proteins may therefore be indicative of the extent of cognitive loss and may reflect progression of the severity of AD.—Goetzl, E. J., Abner, E. L., Jicha, G. A., Kapogiannis, D., Schwartz, J. B. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. FASEB J. 32, 888–893 (2018). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A study on plasma neuronal exosomes of patients with AD dementia revealed declined levels of NPTX2 compared with matched controls.”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Goetzl et al. 2018
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Neuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849 · cited 1×
“Presynaptic neurexin2a (NRXN2a) and the postsynaptic adhesion protein, neuroligin1 (NLGN1), interact trans-synaptically to ensure structural stability and functions of excitatory synapses in the hippocampus and cortex (6, 7).”
BackgroundMustapic, M., Eitan, E., Werner, J. K., Berkowitz, S. T., Lazaropoulos, M. P., Tran, J., Goetzl, E. J., & Kapogiannis, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00278 · Cited by 441
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 220
Sproviero, D., Gagliardi, S., Zucca, S., Arigoni, M., Giannini, M., Garofalo, M., Fantini, V., Pansarasa, O., Avenali, M., Ramusino, M. C., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.785741 · Cited by 31
Yadav, R., Singh, A. V., Kushwaha, S., & Chauhan, D. S. (2024) · International Journal of Microbiology Research · doi:10.4103/ijmr.ijmr_2344_22 · Cited by 33
Qin, Y., Cao, L. K., Zhang, J., Zhang, H., Cai, S., Guo, B., Wu, F., Zhao, L., Li, W., Ni, L., et al. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-01994-z · Cited by 36
Singh, R., Rai, S., Bharti, P. S., Zehra, S., Gorai, P. K., Modi, G. P., Rani, N., Dev, K., Inampudi, K. K., Y., V. V., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03475-z · Cited by 28
Gabrielli, M., Tozzi, F., Verderio, C., & Origlia, N. (2022) · Cells · doi:10.3390/cells12010063 · Cited by 34
Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases
Xu, C. Y., Jiang, C., Li, Z., Gao, H., Xian, J., Guo, W., He, D., Peng, X., Zhou, D., & Li, D. (2024) · MedComm · doi:10.1002/mco2.660 · Cited by 32
Detection and Isolation of Tissue‐Specific Extracellular Vesicles From the Blood
Newman, L. A., & Rowland, A. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70059 · Cited by 28
Pineles, B. L., Mani, A., Sura, L., Rossignol, C., Albayram, S., Weiss, M. D., & Goetzl, L. M. (2021) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2020-321096 · Cited by 28
Cano, A. C., Antonio, E. E., Bernuz, M., Puerta, R., García‐González, P., de Rojas, I., Olivé, C., Pérez‐Cordón, A., Montrreal, L., Núñez‐Llaves, R., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01793-7 · Cited by 30
Sattarov, R., Havers, M., Orbjörn, C., Stomrud, E., Janelidze, S., Laurell, T., & Mattsson, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-75406-0 · Cited by 29
Discovery of Novel Markers for Identifying Cognitive Decline Using Neuron-Derived Exosomes
Zhong, J., Ren, X., Liu, W., Wang, S., Lv, Y., Nie, L., Lin, R., Tian, X., Yang, X., Zhu, F., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.696944 · Cited by 28
Licata, A. E., Zhao, Y., Herrmann, O., Hillis, A. E., Desmond, J. E., Onyike, C. U., & Tsapkini, K. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103329 · Cited by 26
Review on the roles of specific cell-derived exosomes in Alzheimer's disease
Zou, Y., Mu, D., Ma, X., Wang, D., Zhong, J., Gao, J., Yu, S., & Qiu, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.936760 · Cited by 31
Vaz, M., Martins, T. S., & Henriques, A. G. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15697 · Cited by 25
Sjöqvist, S., & Otake, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065237 · Cited by 26
Extracellular Vesicles and Cancer Therapy: Insights into the Role of Oxidative Stress
Ho, J., Chaiswing, L., & Clair, D. K. S. (2022) · Antioxidants · doi:10.3390/antiox11061194 · Cited by 26
Wang, D., Guan, S., Lu, P., Li, Y., & Xu, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114354 · Cited by 24
Cleary, J. A., Kumar, A., Craft, S., & Deep, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14497 · Cited by 25
Onkar, A., Khan, F., Goenka, A., Rajendran, R. L., Dmello, C., Hong, C. M., Mubin, N., Gangadaran, P., & Ahn, B. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c16839 · Cited by 25
Extracellular vesicles reveal abnormalities in neuronal iron metabolism in restless legs syndrome
Chawla, S., Gulyani, S., Allen, R. P., Earley, C. J., Li, X., van Zijl, P. C. M., & Kapogiannis, D. (2019) · SLEEP · doi:10.1093/sleep/zsz079 · Cited by 24
Self-citationChanteloup, G., Cordonnier, M., Moreno‐Ramos, T., Pytel, V., Matías‐Guiu, J., Gobbo, J., Cabrera‐Martín, M. N., Gómez‐Pinedo, U., Garrido, C., & Matías‐Guiu, J. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190545 · Cited by 24
Brahmer, A., Geiß, C., Lygeraki, A., Neuberger, E. W. I., Tzaridis, T., Nguyen, T. T., Luessi, F., Régnier‐Vigouroux, A., Hartmann, G., Simon, P. D., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01308-9 · Cited by 26
Qin, T., Prins, S., Groeneveld, G. J., van Westen, G. J. P., de Vries, H. E., Wong, Y. C., Bischoff, L. J. M., & de Lange, E. C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093158 · Cited by 24
Exosomes: potential targets for the diagnosis and treatment of neuropsychiatric disorders
Li, H., Yuan, Y., Xie, Q., & Dong, Z. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04893-6 · Cited by 25
Biomarkers and Tools for Predicting Alzheimer’s Disease in the Preclinical Stage
Li, T.-R., Yang, Q. Z., Hu, X., & Han, Y. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210524153901 · Cited by 23
Central Nervous System Cell‐Derived Exosomes in Neurodegenerative Diseases
Tian, Y., Fu, C., Wu, Y., Lu, Y. W., Liu, X., & Yunling, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9965564 · Cited by 22
Neuron-derived extracellular vesicle-based diagnostics for Tau and Alzheimer’s disease
Chinnathambi, S., Kumarappan, M., Malik, S., Velmurugan, G., & Chandrashekar, M. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2024.12.006 · Cited by 21
Central Nervous System-Derived Extracellular Vesicles as Biomarkers in Alzheimer’s Disease
Yu, Y., Wang, Z., Chai, Z., Ma, S., Li, A., & Li, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178272 · Cited by 22
A Review of the Pathogenesis and Chinese Medicine Intervention of Alzheimer's Disease
Zhao, J., Yang, J., Li, D., Wang, F., & Li, L. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2201002 · Cited by 21
Guo, Z., Tian, C., Shi, Y., Song, X., Yin, W., Tao, Q., Liu, J., Peng, G.-P., Wu, Z., Wang, Y., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01727-w · Cited by 23
Exosome release and cargo in Down syndrome
Hamlett, E. D., LaRosa, A., Mufson, E. J., Fortea, J., Ledreux, A., & Granholm, A. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22712 · Cited by 21
Abdel–Haq, H. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00493-4 · Cited by 22
Monteiro-Reis, S., Carvalho-Maia, C., Bart, G., Vainio, S. J., Pedro, J., Silva, E. R., Sales, G., Henrique, R., & Jerónimo, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063267 · Cited by 21
Advancing Extracellular Vesicle Research: A Review of Systems Biology and Multiomics Perspectives
Kemunto, G., Ghadami, S., & Dellinger, K. (2025) · PROTEOMICS · doi:10.1002/pmic.70066 · Cited by 21
Innovative Biomarkers for Alzheimer’s Disease: Focus on the Hidden Disease Biomarkers
Ghidoni, R., Squitti, R., Siotto, M., & Benussi, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170953 · Cited by 20
Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases
Izco, M., Carlos, E., & Alvarez‐Erviti, L. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105651 · Cited by 18
Soleymani, T., Chen, T.-Y., Gonzalez‐Kozlova, E., & Dogra, N. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1156821 · Cited by 22
Exosomes in multiple sclerosis and Alzheimer's disease – Adversary and ally
Tang, N. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.100665 · Cited by 21
Counil, H., & Krantic, S. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191237 · Cited by 20
Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia
Zanardini, R., Saraceno, C., Benussi, L., Squitti, R., & Ghidoni, R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.758182 · Cited by 17
Biomarkers and Tools for Predicting Alzheimer's Disease in the Preclinical Stage
Li, T., Yang, Q. Z., Hu, X., & Han, Y. (2022) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 17
Gonul, C. P., Karaçiçek, B., & Genç, Ş. (2025) · Developmental Neurobiology · doi:10.1002/dneu.22984 · Cited by 17
Isolation of extracellular vesicles from human plasma samples: The importance of controls
Tsamchoe, M., Petrillo, S. K., Lazaris, A., & Metrakos, P. P. (2023) · Biotechnology Journal · doi:10.1002/biot.202200575 · Cited by 16
Extracellular vesicle-associated proteins as potential biomarkers
Schou, A. S., Nielsen, J. E., Askeland, A., & Jørgensen, M. M. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.02.011 · Cited by 16
Manzini, V., Cappelletti, P., Orefice, N. S., Brentari, I., Rigby, M. J., Lo Giudice, M., Feligioni, M., Rivabene, R., Crestini, A., Manfredi, F., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04386-z · Cited by 16
Arias-Aragón, F., Tristán‐Clavijo, E., Martínez‐Gallego, I., Robles-Lanuza, E., Coatl-Cuaya, H., Martín-Cuevas, C., Sánchez-Hidalgo, A. C., Moreno, A. R., Martínez-Mir, A., & Scholl, F. G. (2023) · iScience · doi:10.1016/j.isci.2023.106868 · Cited by 17
Ashique, S., Kumar, N., Mishra, N., Muthu, S., Rajendran, R. L., Chandrasekaran, B., Obeng, B. F., Hong, C. M., Krishnan, A., Ahn, B., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155451 · Cited by 16
Narayanan, M., Ayyandurai, M., & Rajinikanth, V. (2024) · Dubai Medical Journal · doi:10.18502/dmj.v7i1.17498 · Cited by 15
Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes
Duggan, M. R., Lu, A., Foster, T. C., Wimmer, M. E., & Parikh, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.834775 · Cited by 15
Inflammatory Mechanisms and Cascades Contributing to Neurocognitive Impairment in HIV/AIDS
Fernandes, N. C., & Pulliam, L. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_100 · Cited by 13
Deng, Z., Chen, H., Chen, J., Du, Z., Zhou, W., & Yuan, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167960 · Cited by 14
Titze-de-Almeida, S. S., Marina, C. L., Ramos, M. V., Silva, L. D. D. S., Brandão, P. R. D. P., Bispo, D. D. D. C., von Glehn, F., & Titze‐de‐Almeida, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178246 · Cited by 13
Biofluid biomarkers for Alzheimer’s disease: past, present, and future
An, C., Cai, H., Ren, Z., Fu, X., Quan, S., & Jia, L. (2024) · Medical Review · doi:10.1515/mr-2023-0071 · Cited by 14
Advancing medicine for Alzheimer’s disease: A plasma neural exosome platform
Goetzl, E. J. (2020) · The FASEB Journal · doi:10.1096/fj.202001655 · Cited by 12
Self-citationLin, S.-P., Lee, W.-J., Sun, M.-C., Yang, Y.-H., Vinzons, L. U., Lin, Y.-M., & Wei, Y.-T. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c12766 · Cited by 11
Antibody biomarker for de novo Parkinson disease: attempted validation
Feng, N., Simanski, S., Islam, K., Hynan, L. S., Kodadek, T. J., & German, D. C. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0064-2 · Cited by 11
Buchman, A. S., Yu, L., Klein, H., Zammit, A. R., Oveisgharan, S., Nag, S., Tickotsky, N., Wolf-Levy, H., Seyfried, N. T., Morgenstern, D., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209223 · Cited by 9
Advancing Alzheimer’s disease therapy through engineered exosomal Macromolecules
Jain, S., Murmu, A., & Chauhan, A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149590 · Cited by 10
Lei, X., Xie, X., Yang, J., & Li, Y. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115954 · Cited by 10
Zhu, Y., Fang, X., Zhang, S., Liao, Y., Lin, H., Chen, P., Yang, M., Huang, J. J., & Wang, X. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s589123 · Cited by 14
Engineered exosomes derived from stem cells: a new brain-targeted strategy
Waqas, A., Huang, S., & Chen, L. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2306877 · Cited by 9
Hiramoto, J. S., Elahi, F. M., Gasper, W. J., Reilly, L. M., Chuter, T. A. M., & Goetzl, E. J. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.10.007 · Cited by 9
Self-citationBiofluid biomarkers for Alzheimer’s disease
Wang, S., Xie, S., Zheng, Q., Zhang, Z., Wang, T., & Zhang, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1380237 · Cited by 9
Cuttler, K., de Swardt, D., Engelbrecht, L., Kriel, J., Cloete, R. E. A., & Bardien, S. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02548-8 · Cited by 8
Melnik, M., Miyoshi, E., Ma, R., Corrada, M. M., Kawas, C. H., Bohannan, R. C., Caraway, C. A., Miller, C. A., Hinman, J. D., John, V., et al. (2024) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2024.110137 · Cited by 8
Current Developments in Alzheimer's Disease
Goetzl, E. J. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2024.08.019 · Cited by 11
Self-citationLombino, F. L., Shafiq, M., Matamoros‐Angles, A., Schwarz, J. R., Gromova, K. V., Stajano, D., Siebels, B., Bergmann, L., Magnus, T. U., Schweizer, M., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70231 · Cited by 6
The role of autophagy in brain health and disease: Insights into exosome and autophagy interactions
Wang, H., Lv, C., Feng, L., Guo, J., Zhao, S., & Jiang, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38959 · Cited by 7
Sánchez-Hidalgo, A. C., Arias-Aragón, F., Romero-Barragán, M. T., Martín-Cuevas, C., Delgado-Garcia, J. M., Martínez-Mir, A., & Scholl, F. G. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113896 · Cited by 7
Pan, W., Teng, Y., Han, X., Liu, S., Pang, X., Wang, L., & Zhao, M. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100193 · Cited by 5
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome
Sauer, M., Gomes, B. F., Shahrouki, P., Lantero‐Rodriguez, J., Montoliu‐Gaya, L., Camporesi, E., Belbin, O., Alcolea, D. A., Kumar, A., Sharma, M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70241 · Cited by 7
Mohan, S., Khamjan, N. A., Abdelwahab, S. İ., Taha, M. M. E., Moshi, J. M., Alshahrani, A. F., Jeraiby, M., Alshahrani, S., Sahli, K. A., Alqhtani, H. A. S., et al. (2025) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.1177/0976500x251361201 · Cited by 5
Gusar, V. A., Кан, Н. Е., Leonova, A., Chagovets, V., Tyutyunnik, V., Khachatryan, Z. V., Львовна, Я. Е., & Sukhikh, G. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041497 · Cited by 5
Extracellular vesicles in Alzheimer's disease
Pinho, V. H. B., Daher, J. P. L., Kanaan, S., & Medeiros, T. (2024) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0044-1779296 · Cited by 6
The promise and challenges of extracellular vesicles in the diagnosis of neurodegenerative diseases
Hagey, D. W., & Andaloussi, S. E. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00014-x · Cited by 5
Işık, M., Sari, H. K., Çağlayan, M. G., Yılmaz, R., & Derkuş, B. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70090 · Cited by 4
Xing, X., Liu, H., Zhang, M., & Li, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1485750 · Cited by 5
Göverti, D., Büyüklüoğlu, N., Kaya, H., Yüksel, R. N., Yücel, Ç., & Göka, E. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06147-z · Cited by 5
Small extracellular vesicles as potential theranostic tools in central nervous system disorders
Guo, M., Wang, L., Yin, Z., Chen, F., & Lei, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115407 · Cited by 4
NPTX2 transfection improves synaptic E/I balance and performance in learning impaired aged rats
Severín, D., Koh, M. T., Moreno, C., Contreras, D., Contreras, A., Wesselborg, C., Bridi, M., Atufa, J., Branch, A., Worley, P. F., et al. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102746 · Cited by 3
Shi, Y., Bao, Q., Chen, W., Wang, L., Peng, D., Liu, J., Liu, Q., Zhang, Y., Ji, Z., & Shen, A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215666 · Cited by 3
Umesh, M., Singaravelu, V., Daulatabad, V. S., Kamble, P., Singhal, A., John, N. A., & John, J. (2022) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2022-0015 · Cited by 3
The Role of Pentraxin 3 in Gastrointestinal Cancers
Zajkowska, M., & Mroczko, B. (2023) · Cancers · doi:10.3390/cancers15245832 · Cited by 3
Landon, B., Subasinghe, K., Sumien, N., & Phillips, N. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112745 · Cited by 3
Advances in Alzheimer's Disease Biomarkers
Li, K., Gao, Y., Liu, M., & Chen, Y. (2024) · Current Alzheimer Research · doi:10.2174/0115672050366767241223050957 · Cited by 3
An emerging spectrum of therapeutic targets for Alzheimer's disease
Goetzl, E. J. (2023) · The FASEB Journal · doi:10.1096/fj.202301461r · Cited by 2
Self-citationDiagnostic and Prognostic Laboratory Testing for Alzheimer Disease
Winder, Z., Wilcock, D. M., & Jicha, G. A. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2020.05.003 · Cited by 2
Self-citationThe fluid biomarkers of Alzheimer’s disease
Peng, Q., & Zhang, Z. (2021) · Brain Science Advances · doi:10.26599/bsa.2021.9050001 · Cited by 1
Fernandes, M. G. F., Pinard, M., Sokullu, E., Tremblay, C., Gagnon, J., Calon, F., Coulombe, B., & Brouillette, J. (2026) · The Journals of Gerontology Series A · doi:10.1093/gerona/glag009 · Cited by 1
Single-vesicle analyses validate L1CAM as a marker of neuron-derived extracellular vesicles in bloodPreprint
Kapogiannis, D., Nogueras‐Ortiz, C. J., Eren, E., Yao, P. J., Calzada, L., Dunn, C., Volpert, O. V., Delgado‐Peraza, F., Mustapić, M., Vreones, M. P., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1658979/v1 · Cited by 1
Self-citationNielsen, J. E. (2021) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau455017331
Application of Exosomes in Medical Field
Zhao, P. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.132185
Role of fluid biomarkers in the early diagnosis of Alzheimer’s disease
Vo, G. V., Nguyen, M. N., & Toi, V. V. (2021) · Science & Technology Development Journal - Health Sciences · doi:10.32508/stdjhs.v2i1.458
A Comprehensive Review of Exosomes with Therapeutic Potential in Cancer and Coeliac Disease
Assainar, F., Thomas, J. G., Saleem, Z., Thekkekara, S., Mammoo, F., & Kallan, N. N. (2024) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2024.123003
A nested case-control study of plasma-based extracellular vesicles biomarkers of Alzheimer’s diseasePreprint
Yang, L., He, L., Wang, Y., Cheng, X., Yu, C., & Yan, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4578906/v1
Pharmacological impacts on laboratory biomarkers: A guide for nurses and laboratory professionals
Almohammadi, A. S., Alraggas, T. M., Alshammri, F. M., Rashad, . I., Alotaiby, N. L. M., Alotaiby, A. A. S., Almutairi, N. S., Al-Falih, T. A., Khader, A. K. H., Alanazi, H. M. H., et al. (2020) · International Journal of Health Sciences · doi:10.53730/ijhs.v4ns1.15344
Extracellular vesicles as biomarker and therapeutic targets for neurological disorders
Razi, U., Ahmad, F., Karan, A., Sundar, V., & DeCoster, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23891-8.00007-x
Hu, G., Wang, K., Wu, C., Liu, Q., Zhang, Q., Ai, Q., & Huang, M. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02374-z
Extracellular Vesicles as Biomarkers of Alzheimer Disease and Related Dementias
Mianoor, Z., Phelps, J., & Badhwar, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_18
Chandra, P. K., Selvam, M. K. P., Zulfiquar, T., Rutkai, I., Sikka, S. C., Braun, S. E., Rappaport, J., & Busija, D. W. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02464-w
Metadata
- Authors
- Goetzl, E. J., Abner, E. L., Jicha, G. A., Kapogiannis, D., & Schwartz, J. B.
- Affiliations
- University of California, San Francisco (US)
- University of Kentucky (US)
- National Institute on Aging (US)
- Corresponding author
- Goetzl, Edward J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2018-01-04
- Volume
- 32
- Issue
- 2
- Pages
- 888-893
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC5888398
- OpenAlex
- W2761598264
- Cited by
- 219
- References
- 28
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 29 · 2023: 27 · 2022: 38 · 2021: 30 · 2020: 21 · 2019: 26 · 2018: 12
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30AG028383)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, plasma biomarkers, NPTX2, neuroligin-1, excitatory synapses, cognitive decline, disease progression, preclinical Alzheimer's disease, synaptic proteins
- MeSH terms
- Pentraxins, Aged, Alzheimer Disease, C-Reactive Protein, Female, Humans, Male, Nerve Tissue Proteins, Neurons, Synaptic Membranes, Cell Adhesion Molecules, Neuronal, Receptors, AMPA, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review